# Teva Czech Industries s.r.o. - Inspection Records

Source: https://www.keypedia.com/companies/teva-czech-industries-sro/2a136d23-d81f-49b6-accf-a12f7e28c07b

> Inspection records and compliance data for Teva Czech Industries s.r.o. in Opava, None. Access full analysis and detailed observations.

---

## Details

- Name: Teva Czech Industries s.r.o.
- FEI Number: 1000282452
- City: Opava
- State: None
- Country Name: Czech Republic
- Address Line 1: Ostravska 305/29
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [Canada Inspection - Teva Czech Industries s.r.o. - Inspection #83948 - 2022-09-08](https://www.keypedia.com/records/canada_inspection/teva-czech-industries-sro/48a16d45-9fd6-47e0-a3a4-c840acf57e3f) — source: Canada, date: September 8, 2022
- [FDA Inspection 1207600 - Teva Czech Industries s.r.o. - 2022-09-08](https://www.keypedia.com/records/fda_inspections/teva-czech-industries-sro/771ce47e-014c-4dbb-b53d-3e966d0f5db0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 8, 2022
- [Canada Inspection - Teva Czech Industries s.r.o. - Inspection #79064 - 2020-09-17](https://www.keypedia.com/records/canada_inspection/teva-czech-industries-sro/9d642f1c-c39a-4e25-aae1-35075b1cdb03) — source: Canada, date: September 17, 2020
- [FDA Inspection 1152783 - Teva Czech Industries s.r.o. - 2020-09-17](https://www.keypedia.com/records/fda_inspections/teva-czech-industries-sro/2925aae1-56a3-4fde-85fc-8c4d433b6118) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 17, 2020
- [Canada Inspection - Teva Czech Industries s.r.o. - Inspection #75307 - 2018-09-13](https://www.keypedia.com/records/canada_inspection/teva-czech-industries-sro/8b41eb42-d147-42f1-b5f9-76a23077cab7) — source: Canada, date: September 13, 2018
- [FDA Inspection 1097960 - Teva Czech Industries s.r.o. - 2018-09-13](https://www.keypedia.com/records/fda_inspections/teva-czech-industries-sro/8069341c-b30d-4b0d-8db0-305ad3d73fbf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 13, 2018
- [FDA Inspection 1011464 - Teva Czech Industries s.r.o. - 2017-03-24](https://www.keypedia.com/records/fda_inspections/teva-czech-industries-sro/9268f8f3-5736-4971-9c79-a03b2e368b18) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 24, 2017
- [483 - Teva Czech Industries s.r.o. - 2017-03-20](https://www.keypedia.com/records/483/teva-czech-industries-sro/10b4b052-0f6d-4ba4-8432-8b97f26d8e48) — source: FDA, date: March 20, 2017
- [Canada Inspection - Teva Czech Industries s.r.o. - Inspection #68356 - 2016-11-11](https://www.keypedia.com/records/canada_inspection/teva-czech-industries-sro/60f2144e-9c93-46a6-a12b-0cf3943ba506) — source: Canada, date: November 11, 2016
- [Canada Inspection - Teva Czech Industries s.r.o. - Inspection #14645 - 2014-11-14](https://www.keypedia.com/records/canada_inspection/teva-czech-industries-sro/b125a138-23fa-4fce-b262-b4679656a4f2) — source: Canada, date: November 14, 2014
- [FDA Inspection 876906 - Teva Czech Industries s.r.o. - 2014-03-21](https://www.keypedia.com/records/fda_inspections/teva-czech-industries-sro/9f5e419a-e4d2-414d-8ff9-3eafbd78cbda) — classification: No Action Indicated (NAI), source: FDA, date: March 21, 2014
- [Canada Inspection - Teva Czech Industries s.r.o. - Inspection #1833 - 2012-10-25](https://www.keypedia.com/records/canada_inspection/teva-czech-industries-sro/1be56721-a03e-43c4-9780-f5785c09124a) — source: Canada, date: October 25, 2012
- [FDA Inspection 748067 - Teva Czech Industries s.r.o. - 2011-09-22](https://www.keypedia.com/records/fda_inspections/teva-czech-industries-sro/b129e182-c7d5-4020-98b2-072b0a0bd58a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 22, 2011
- [FDA Inspection 668005 - Teva Czech Industries s.r.o. - 2010-06-01](https://www.keypedia.com/records/fda_inspections/teva-czech-industries-sro/a041928e-122c-4a56-b425-8f7aac1704dc) — classification: No Action Indicated (NAI), source: FDA, date: June 1, 2010

## Related Companies

- [Merck S.L.](https://www.keypedia.com/companies/merck-sl/17cee6a3-6d32-4c4b-94fd-7ed12979ccf2)
- [Barr Laboratories Inc.](https://www.keypedia.com/companies/barr-laboratories-inc/c462b6c3-5357-4446-9aad-53dd2b49b1ce)
- [IntelliPharmaCeutics Corp.](https://www.keypedia.com/companies/intellipharmaceutics-corp/78f18be2-f4f4-44f4-88d7-30d9f8f36ac5)
- [Italfarmaco S.p.A.](https://www.keypedia.com/companies/italfarmaco-spa/43c36cab-e301-4482-b9f7-b042cce56271)
- [Elysium Pharmaceuticals Limited](https://www.keypedia.com/companies/elysium-pharmaceuticals-limited/6249fc41-1206-431f-87ee-b7b13c89e8f4)
- [Novartis Pharma Stein AG](https://www.keypedia.com/companies/novartis-pharma-stein-ag/06be1f01-8421-471e-9d38-475fef9a9c5b)
- [Particle Dynamics LLC](https://www.keypedia.com/companies/particle-dynamics-llc/0fdd4014-06a4-402c-9438-71b62c24f197)
- [Boehringer Ingelheim Pharma GmbH & Co. KG](https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/bcb705bf-98ed-451f-a79d-b6223d2ed263)
- [Boehringer Ingelheim Pharma Gmbh & Co Kg](https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/5b2ffd33-30ee-4e73-bb66-fa96b4549154)
- [Eli Lilly & Company](https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf)

## Related Officers

- [Senior Compliance Manager](https://www.keypedia.com/people/christina-a-miller/7893b145-2814-4443-a886-29881db45918)
- [Laurimer Kuilan-Torres](https://www.keypedia.com/people/laurimer-kuilan-torres/a7f49e33-9d35-4dfe-8bcc-d369d3834ef4)